DNA METHYLATION
Guided by:Presented by:
SUSHMA MARLAM.PHARM (First Sem)DEPT. OF BIOTECH.
PROF. KALPANA JOSHIPROF. & HEADBIOTECH. DEPT.SCOE. PUNE.
1
EpigeneticsEpigeneticsEpigeneticsEpigenetics
• Study of heritable changes in gene expression that occur without a change in a DNA sequence.
• Stable alteration in gene expression pattern.• Dynamic process that plays a key role in normal cell
growth and differentiation.• To date, the best understood epigenetic mechanisms
are
1. DNA methylation
2. Histone modifications
2
DNA methylationDNA methylationDNA methylationDNA methylation
• DNA methylation is one of the most commonly occurring epigenetic events taking place in the mammalian genome.
• This change, though heritable, is reversible, making it a therapeutic target.
• Methylation pattern is determined during embryogenesis and passed over to differentiating cells and tissues.
3
DNA methylationDNA methylationDNA methylationDNA methylation
• DNA structure is maintained from generation to generation.
• This structure is modified by base methylation in nearly all cells and organisms.
4
DNA methylationDNA methylationDNA methylationDNA methylation
• The DNA of most organisms is modified by a post-replicative process which results in three types of methylated bases in DNA:
C5-methylcytosine(5-mc)
N4-methylcytosine
N6-methyladenine. • This Modification is called DNA methylation.• DNA methylation is a covalent modification of DNA
that does not change the DNA sequence, but has an influence on gene activity.
Wide spread in prokaryotes
5
DNA MethylationDNA MethylationDNA MethylationDNA Methylation
• It occurs in the cells of fungi, plants, non-vertebrates and vertebrates.
• In vertebrates, 3-6% of DNA cytosine is methylated.
• No methylation in many insects and single-celled eukaryotes.
• In plants, 30% of DNA cytosine is methylated.
6
DNA DNA methylationmethylationDNA DNA methylationmethylation•Addition of methyl group to C-5 position of cytosine residues.• Most cytosine methylation occurs in the sequence context 5'CG3' •Occurs almost exclusively at cytosines that are followed immediately by a Guanine- CpG Dinucleotide.
7
MechanismMechanismMechanismMechanism
• Methyl groups are transferred from S-adenosyl methionine in a reaction catalysed by a DNA methyl transferases(DNMT) or methylases.
• SAM is then converted to SAH (S-adenosyl homocysteine).
8
Enzymes involved in DNA Enzymes involved in DNA methylationmethylationEnzymes involved in DNA Enzymes involved in DNA methylationmethylation
• Enzymes involved-
DNA METHYLTRANSFERASES(DNMTs)• DNMTs catalyze this reaction at different times during the cell
cycle.• In Mammals,
1. DNMT1- Maintainance methylase
2. DNMT 2
3. DNMT3a and DNMT3b-‘de novo’methylases
4. DNMT3L
9
EnzymesEnzymesEnzymesEnzymesDNMT1: • maintains the pattern of DNA methylation after DNA
replication.• requires a hemi-methylated DNA substrate and will
faithfully reproduce the pattern of DNA methylation on the newly synthesized strand.
• DNA methylation- ‘an automatic semi conservative mechanism’
DNMT3a and DNMT3b:• Will add methyl groups to CG dinucleotides which are
previously unmethylated on both the strands.• Re-establish the methylation pattern.
10
11
PRE-IMPLANTATION
Genome undergoes Demethylation
AFTER IMPLANTATION OF
EMBRYO AND DURING
CARCINOGENESIS
New Methylation patterns are set by de-
novo methylation.
DURING REPLICATION
Methylation patterns must be maintained. Therefore, DNMT1,
methylates the hemimethylated DNA after strand synthesis.
12
Mammalian GenomeMammalian GenomeMammalian GenomeMammalian Genome
• The human genome is not methylated uniformly and contains regions of unmethylated segments interspersed by methylated regions.
• In contrast to the rest of the genome, smaller regions of DNA, called CpG islands, ranging from 0.5 to 5 kb and occurring on average every 100 kb, have distinctive properties. These regions are unmethylated normally.
• Approximately half of all the genes in humans have CpG islands, and these are present on both housekeeping genes and genes with tissue-specific patterns of expression.
13
CpG DinucleotidesCpG DinucleotidesCpG DinucleotidesCpG Dinucleotides• Occur at low abundance throughout the human
genome.• Tend to concentrate in regions known as CpG CpG
islands islands (found in 50% of promoter regions of genes).
• Typically methylated in non-promoter regions and unmethylated in promoter regions.
• Methylation within the promoter region correlates with transcriptional silencing.
• Methylation of CpG islands is believed to dysregulate gene transcription through the inhibition of transcription factor binding either directly or via altered histone acetylation. 14
CpG ISLANDS
PROMOTER REGIONS
NON-PROMOTER
REGIONS
Non-methylated
Methylated
Binding of TF
Transcription
Inhibition of TF binding
Transcriptional silencing
Methylated Non-methylated
Silence parasitic genetic
elements
Genomic stability
Binding of TF
Transcription
15
16
Role of DNA methylationRole of DNA methylationRole of DNA methylationRole of DNA methylation
• Plays a role in long term silencing of gene.• Plays a role in silencing of repetitive elements ( eg:
transposons).• Plays a role in X-chromosome inactivation.• In the establishment and maintenance of imprinted
genes.• Suppresses the expression of viral genes and other
deletorious elements that have been incorporated into the genome of the host over time.
• In Carcinogenesis.
17
18
19
METHYLATION IMBALANCE may contribute to TUMOR PROGRESSION
GLOBAL HYPOMETHYLATION
DNA HYPERMETHYLATION
Observed in neoplastic cells
May induce neoplastic transformation
Genomic instability, Abnormal chromosomal
structures andActivating oncogenes.
Inactivation of tumor-suppressor genes: p16,
BRCA1
Inactivation of DNA repair genes: MLH1, MGMT
20
A CpG island hypermethylation profile of human cancer
21
Global HypomethylationGlobal HypomethylationGlobal HypomethylationGlobal Hypomethylation
• There will be significant decrease in 5-meC.• Occurs in numerous solid tumors and in some
haematological malignances.
eg: Chronic lymphocytic leukaemia (CLL),
Chronic myelogenous leukaemia (CML),
Acute Myelogenous leukaemia (AML).• Occurs in early stages of chest tumors, colorectal
cancer and chronic lymphocytic leukaemia
22
ExceptionsExceptionsExceptionsExceptions
• There are some examples where a CpG island in a promoter is unmethylated while the gene is still kept silent.
eg: The CpG island in human α-globin gene promoter is unmethylated in both erythroid and non-erythroid tissues (Bird et al., 1987).
Reason: role of histone modifications in gene silencing.
23
• Carcinogens: Chronic exposure of human bronchial epithelial cells to tobacco-derived carcinogens drives hypermethylation of several tumor suppressor genes.
• The reactive oxygen species (ROS) associated with chronic inflammation is another source of DNA damage.
• Cigarette smoke: causes hypomethylation.• Aging.
24
RISK FACTORSRISK FACTORS RISK FACTORSRISK FACTORS
Detection of DNA methylationDetection of DNA methylationDetection of DNA methylationDetection of DNA methylation
1. Sodium bisulfite conversion (SBC)
2. SBC LC-MS-MS
3. cDNA microarray
4. Restriction landmark genomic sequencing
5. CpG island microarray
25
1. Bisulfite conversion (SBC)1. Bisulfite conversion (SBC)1. Bisulfite conversion (SBC)1. Bisulfite conversion (SBC)• Offers highest degree of
resolution of the methylation status of a given sample, allowing to determine the positional CpG genotype for individual samples.
• Involves the chemical modification of DNA by bisulfite treatment, where sodium bisulfite deaminates cytosine to uracil.
• Methylated cytosine is resistant to this conversion.
26
Major Advance: Conversion of unmethylated cystosinesto uracil using sodium bisulfite
Sequencing: unemethylated cytosines read as thymidine in sense strand; adenine in the
anti-sense strand.Other technologies evolved from here.
27
• After bisulfite modification, there are a number of methods available to study CpG island methylation.
• These include sequencing,
methylation-specific polymerase chain reaction, combined bisulfite restriction analyses,
methylation-sensitive single nucleotide primer extension, and
methylation-sensitive single-strand conformational polymorphism.
28
1. SBC contd..1. SBC contd..1. SBC contd..1. SBC contd..
1. SBC contd..1. SBC contd..1. SBC contd..1. SBC contd..• To be useful as a routine diagnostic tool, the actual
methylation detection method has to be sensitive, quick, easy, and reproducible.
• After bisulfite modification, PCR is performed using two sets of primers designed to amplify either methylated or unmethylated alleles.
• Of the various techniques available, methylation-specific polymerase chain reaction (MSP) seems to be most useful at present.
29
30
Methylation specific PCR
31
DNA methylation inhibitors (clinical DNA methylation inhibitors (clinical approach)approach)DNA methylation inhibitors (clinical DNA methylation inhibitors (clinical approach)approach)
• Agents targetted against DNMTs
5-azacytidine
2'deoxy-5-azacytidine (also known as Decitabine)
32
ReferencesReferencesReferencesReferences• Wentao Gao et al, Carcinogenesis vol.29 no.10 pp.1901–
1910, 2008• J.A. McKay*1, E.A. Williams† and J.C. Mathers*, Biochemical
Society Transactions (2004) Volume 32, part 6• Robin Holliday, Biochemistry (Moscow), Vol. 70, No. 5, 2005,
pp. 500-504.• Ibáñez de Cáceres and P. Cairns, Clin Transl Oncol (2007)
9:429-437• Melissa Conerly1 and William M. Grady2,3,*, Disease Models
& Mechanisms 3, 290-297 (2010)• Steven s. smith*, Proc. Nati. Acad. Sci. USA Vol. 89, pp.
4744-4748, May 1992,Biochemistry.
33
ReferencesReferencesReferencesReferences• Manel Esteller, Human Molecular Genetics, 2007, Vol. 16,
Review Issue 1 R50–R59.• Yaping Li et al, Journal of Dermatological Science 54 (2009)
143–149.
34
35
Top Related